Viewing Study NCT03232892


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-02-23 @ 2:21 AM
Study NCT ID: NCT03232892
Status: TERMINATED
Last Update Posted: 2019-12-03
First Post: 2017-07-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer
Sponsor: University of California, San Francisco
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 166521
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None OTHER View